Joseph Himle, Ph.D., associate director of the anxiety disorders program in psychiatry, and associate professor of psychiatry and social work, discussed risk factors for the co-occurrence of depression and anxiety and treatment options that have applications for both disorders in Psychology Today.
ANN ARBOR, Mich. — As loved ones with dementia disappear into symptoms of aggression, agitation or delusions, families are left with few good medical solutions. A new generation of antipsychotic medications gained popularly in the 1990s because they avoided side effects such as Parkinson’s syndrome associated with conventional antipsychotic medications used to treat dementia. But
ANN ARBOR, Mich. — Numerous studies have shown that the brain molecule neuropeptide Y (NPY) helps to restore calm after stressful events. A team of University of Michigan-led researchers has now found that people whose genes predispose them to produce lower levels of NPY are more responsive to negative stimuli in key brain circuits related
‘Early Detection and Intervention’ is this year’s theme for the annual U-M Depression on College Campuses conference ANN ARBOR, Mich. – The devastating shooting near Tucson, Ariz. that left six people dead and U.S. Rep. Gabrielle Giffords critically injured thrust mental health on college campuses back into the national spotlight. In the tragedy’s aftermath, many
The new national list includes 433 U-M physicians – up from 396 who were honored in the last listing two years ago – and places them among the top 5 percent of doctors in their specialties. U-M has more physicians recognized than any other health system in Michigan.
Inpatient unit renovation adds new security features, more private rooms and additional treatment space ANN ARBOR, Mich. — Even on a gray winter day, the space is bright and welcoming, the furniture elegantly accented with leaves and flowing designs. When you first walk in, you might think you had entered a boutique clinic rather than
U-M participates in nationwide study to compare two mood-stabilizing medications for bipolar disorder
ANN ARBOR, Mich. — The University of Michigan is participating in a new clinical trial to compare the effectiveness of two medicines commonly used to treat bipolar disorder. U-M is one of 10 sites in the Bipolar Trials Network that will participate in the national study, which is supported by a federal investment aimed at
David T. Hsu, Ph.D, Ilan A. Kerman, M.D., Ph.D, and Maria Muzik, M.D. were announced today as 2010 NARSAD Young Investigator grantees for work in brain and behavior research.
The Archives of General Psychiatry has just published a U-M meta-analysis that adds to the evidence of a connection between an individual’s ability to respond to stress and a gene that regulates serotonin. The study (supported in part by the Depression Center) was led by Srijan Sen, MD, PhD, assistant professor of psychiatry, and also included
ANN ARBOR, Mich. — University of Michigan Health System researchers have found new evidence that our genes help determine our susceptibility to depression. Their findings, published online today in the Archives of General Psychiatry, challenge a 2009 study that called the genetic link into question and add new support to earlier research hailed as a